0 followers
Mythic Therapeutics’ innovative FateControl technology expands the potential of Antibody Drug Conjugates (ADCs) to destroy cancer and avoid normal cells.
Industries
Headquarters
Stage
Employees
Links
8 members
5 members
2 members
1 members
Bio-Rad Laboratories
11 followers
BioMarin Pharmaceutical
21 followers
Adaptive Biotechnologies
Agilent Technologies
60 followers
Regeneron
77 followers
Discover companies
